Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys

NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, 2001, Osteoporosis prevention, diagnosis, and therapy, JAMA, 285, 785, 10.1001/jama.285.6.785 Russell, 1974, Diphosphonates in Paget's disease, Lancet, 303, 894, 10.1016/S0140-6736(74)90347-X Fleisch, 1991, Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease, Drugs, 42, 919, 10.2165/00003495-199142060-00003 Black, 1996, Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures, Lancet, 348, 1535, 10.1016/S0140-6736(96)07088-2 Harris, 1999, Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial, JAMA, 282, 1344, 10.1001/jama.282.14.1344 Chesnut, 2004, Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis, J Bone Miner Res, 19, 1241, 10.1359/JBMR.040325 Black, 2007, Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis, N Engl J Med, 356, 1809, 10.1056/NEJMoa067312 Body, 1998, Current use of bisphosphonates in oncology, J Clin Oncol, 16, 3890, 10.1200/JCO.1998.16.12.3890 Seedor, 1991, The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats, J Bone Miner Res, 6, 339, 10.1002/jbmr.5650060405 Toolan, 1992, Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats, J Bone Miner Res, 7, 1399, 10.1002/jbmr.5650071207 Bauss, 2002, Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats, J Rheumatol, 29, 2200 Hornby, 2003, Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats, Calcif Tissue Int, 72, 519, 10.1007/s00223-002-2015-4 Itoh, 2002, Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate, J Bone Miner Res, 17, 534, 10.1359/jbmr.2002.17.3.534 Smith, 2003, Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys, Bone, 32, 45, 10.1016/S8756-3282(02)00923-7 Binkley, 1998, Zoledronate prevents the development of absolute osteopenia following ovariectomy in adult rhesus monkeys, J Bone Miner Res, 13, 1775, 10.1359/jbmr.1998.13.11.1775 Balena, 1993, The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates, J Clin Invest, 92, 2577, 10.1172/JCI116872 Dunford, 2001, Structure–activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates, J Pharmacol Exp Ther, 296, 235 Mori, 2002, Effects of long-term treatment with minodronate on bone loss and mechanical strength in ovariectomized rat, Osteoporosis Int, 13, S38 Yoshida, 1998, Responses of trabecular and cortical bone turnover and bone mass and strength to bisphosphonate YH529 in ovariohysterectomized beagles with calcium restriction, J Bone Miner Res, 13, 1011, 10.1359/jbmr.1998.13.6.1011 Yamane, 2003, Effect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen-induced arthritis, Arthritis Rheum, 48, 1732, 10.1002/art.10987 Zhang, 2003, A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice, Clin Exp Metastasis, 20, 153, 10.1023/A:1022621622063 Sasaki, 1998, Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice, Int J Cancer, 77, 279, 10.1002/(SICI)1097-0215(19980717)77:2<279::AID-IJC18>3.0.CO;2-6 Goodman, 1977, Composite pattern of circulating LH, FSH, estradiol, and progesterone during the menstrual cycle in cynomolgus monkeys, Proc Soc Exp Biol Med, 155, 479, 10.3181/00379727-155-39834 Jerome, 1994, Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry, J Bone Miner Res, 9, 527, 10.1002/jbmr.5650090413 Jerome, 1997, Decreased bone mass and strength in ovariectomized cynomolgus monkeys (Macaca fascicularis), Calcif Tissue Int, 60, 265, 10.1007/s002239900227 Hiyaoka, 1994, Age-related changes in bone mineral density, mean width and area of the lumbar vertebrae in male African green monkeys (Cercopithecus aethiops), Exp Anim, 43, 235, 10.1538/expanim1978.43.2_235 Parfitt, 1987, Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee, J Bone Miner Res, 2, 595, 10.1002/jbmr.5650020617 Usui, 1994, Sensitive determination of a novel bisphosphonate, YM529, in plasma, urine and bone by high-performance liquid chromatography with fluorescence detection, J Chromatogr, 652, 67, 10.1016/0378-4347(93)E0397-9 Lundon, 1993, The longterm effect of ovariectomy on the quality and quantity of cortical bone in the young cynomolgus monkey: a comparison of density fractionation and histomorphometric techniques, Bone, 14, 389, 10.1016/8756-3282(93)90169-B Jerome, 2001, Treatment with human parathyroid hormone (1–34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis), Bone, 28, 150, 10.1016/S8756-3282(00)00430-0 Müller, 2004, Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey, J Bone Miner Res, 19, 1787, 10.1359/JBMR.040809 Azuma, 1995, Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models, Bone, 16, 235, 10.1016/8756-3282(94)00035-X Chesnut, 2001, Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture, J Bone Miner Res, 16, 2163, 10.1359/jbmr.2001.16.12.2163 Riggs, 1990, Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis, N Engl J Med, 322, 802, 10.1056/NEJM199003223221203 Lafage, 1995, Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study, J Clin Invest, 95, 2127, 10.1172/JCI117901